NDAINJECTIONINJECTABLE
Approved
Jan 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
3/8 — Basic
Drug data last refreshed 6h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HALDOL (haloperidol decanoate) is a long-acting injectable antipsychotic approved in 1986 for managing schizophrenia and other psychotic disorders. It is a first-generation typical antipsychotic that blocks dopamine receptors in the central nervous system. This depot formulation provides sustained therapeutic levels over weeks, improving medication adherence in chronic psychotic conditions.
LOE Approaching
With LOE approaching and moderate competitive pressure (30%), teams are likely consolidating and focusing on retention rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT
Started Jun 2013
0Migraine HeadachesNauseaRestlessness
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
Started Apr 1987
30 enrolled
Psychosis
Career Relevance
HALDOL (haloperidol decanoate) currently shows zero linked job openings, indicating minimal active hiring and limited career expansion on this asset. Working on HALDOL positions you in a mature, declining product with emphasis on managing legacy revenue rather than building growth capabilities.
Brand Manager
Worked on HALDOL at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.